Search for:

Thursday 29th December 2005


Print
Email
Text size
Comment

NextGen to launch


NextGen Sciences, the Huntingdon-headquartered protein technology specialist, is looking to raise up to £2.4 million with the aid of adviser Seymour Pierce, ahead of its planned AIM flotation tomorrow.

Founded in 2000, NextGen has developed a series of systems that allow researchers to better understand the role proteins can play in disease diagnosis and drug discovery. Protein analysis instrument a2DE Optimizer and gene cloning robotic system The Expression Factory are among the technologies offered by the company, via offices in Cambridgeshire and Philadelphia and a network of Far East distributors.

East of England-focused private equity fund Create Partners, which has backed the company on four further occasions since completing an initial investment in February 2004, will retain a 16.2 per cent stake post-flotation.

There are currently no comments on this post.

 

Related Articles


People who read this article also read ...

Related sections

Interesting links

 
Would you float on AIM?
No chance
Maybe in the future
We're already listed

Editor's Pick

Shareholder activism is on the march, provoked by bad corporate stewardship, the inevitable disappointments of business in a downturn, changes in the law and a new breed of opportunistic investor. GrowthBusiness investigates.
 

Other News

Capital Fund backs food businesses
Vodafone extends Australian coverage
Second round of investment for Mydeco

Advice

How to float on AIM
Corporate hospitality
Managing your wealth

Growth Issues

Delisting: the great escape
Doing business in Russia
UK businesses in India
There are 61 posts

Research

Cash shells’ resources multiply
Powering a renewable revolution
How to improve your year-end numbers
  Job Vacancies | About Us | Contact | Disclaimer | Copyright | Privacy Policy |Site Map